172 related articles for article (PubMed ID: 1444299)
1. Antimicrobial susceptibilities and beta-lactamase characterization of Capnocytophaga species.
Roscoe DL; Zemcov SJ; Thornber D; Wise R; Clarke AM
Antimicrob Agents Chemother; 1992 Oct; 36(10):2197-200. PubMed ID: 1444299
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of 96 Capnocytophaga strains, including a beta-lactamase producer, to new beta-lactam antibiotics and six quinolones.
Arlet G; Sanson-Le Pors MJ; Casin IM; Ortenberg M; Perol Y
Antimicrob Agents Chemother; 1987 Aug; 31(8):1283-4. PubMed ID: 3498438
[TBL] [Abstract][Full Text] [Related]
3. In vitro susceptibilities of Capnocytophaga isolates to beta-lactam antibiotics and beta-lactamase inhibitors.
Jolivet-Gougeon A; Buffet A; Dupuy C; Sixou JL; Bonnaure-Mallet M; David S; Cormier M
Antimicrob Agents Chemother; 2000 Nov; 44(11):3186-8. PubMed ID: 11036049
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial treatment of Capnocytophaga infections.
Jolivet-Gougeon A; Sixou JL; Tamanai-Shacoori Z; Bonnaure-Mallet M
Int J Antimicrob Agents; 2007 Apr; 29(4):367-73. PubMed ID: 17250994
[TBL] [Abstract][Full Text] [Related]
5. Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. centers.
Appelbaum PC; Spangler SK; Jacobs MR
Antimicrob Agents Chemother; 1990 Aug; 34(8):1546-50. PubMed ID: 2221864
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of Capnocytophaga species to 29 antimicrobial agents.
Rummens JL; Gordts B; Van Landuyt HW
Antimicrob Agents Chemother; 1986 Nov; 30(5):739-42. PubMed ID: 3800350
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic resistance and the presence of
Matsumoto T; Matsumoto-Matsubara M; Horiuchi K; Arai E; Negishi T; Natori T; Kawakami Y
J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34668852
[No Abstract] [Full Text] [Related]
8. Beta-lactamase production and antimicrobial susceptibility of subgingival bacteria from refractory periodontitis.
Handal T; Olsen I; Walker CB; Caugant DA
Oral Microbiol Immunol; 2004 Oct; 19(5):303-8. PubMed ID: 15327642
[TBL] [Abstract][Full Text] [Related]
9. cfxA expression in oral clinical Capnocytophaga isolates.
Tamanai-Shacoori Z; Monfort C; Oliviero N; Gautier P; Bonnaure-Mallet M; Jolivet-Gougeon A
Anaerobe; 2015 Oct; 35(Pt B):68-71. PubMed ID: 26204794
[TBL] [Abstract][Full Text] [Related]
10. Novel beta-lactamase from Capnocytophaga sp.
Foweraker JE; Hawkey PM; Heritage J; Van Landuyt HW
Antimicrob Agents Chemother; 1990 Aug; 34(8):1501-4. PubMed ID: 2221858
[TBL] [Abstract][Full Text] [Related]
11. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of beta-lactamase production of multiple resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli.
Tsuji H; Ohashi Y; Okumura K; Tsuji A; Muto Y; Goto S
Chemotherapy; 1982; 28(1):26-39. PubMed ID: 7035089
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of beta lactamase-producing anaerobic oral bacteria in South African patients with chronic periodontitis.
Patel M
SADJ; 2011 Oct; 66(9):416-8. PubMed ID: 23193871
[TBL] [Abstract][Full Text] [Related]
14. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
15. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
16. Capnocytophaga in the dental plaque of immunocompromised children with cancer.
Sixou JL; Aubry-Leuliette A; De Medeiros-Battista O; Lejeune S; Jolivet-Gougeon A; Solhi-Pinsard H; Gandemer V; Barbosa-Rogier M; Bonnaure-Mallet M
Int J Paediatr Dent; 2006 Mar; 16(2):75-80. PubMed ID: 16430520
[TBL] [Abstract][Full Text] [Related]
17. Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal.
Féria C; Ferreira E; Correia JD; Gonçalves J; Caniça M
J Antimicrob Chemother; 2002 Jan; 49(1):77-85. PubMed ID: 11751770
[TBL] [Abstract][Full Text] [Related]
18. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
Vanjak D; Muller-Serieys C; Picard B; Bergogne-Berezin E; Lambert-Zechovsky N
Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):972-8. PubMed ID: 8654448
[TBL] [Abstract][Full Text] [Related]
19. Capnocytophaga ochracea: characterization of a plasmid-encoded extended-spectrum TEM-17 beta-lactamase in the phylum Flavobacter-bacteroides.
Rosenau A; Cattier B; Gousset N; Harriau P; Philippon A; Quentin R
Antimicrob Agents Chemother; 2000 Mar; 44(3):760-2. PubMed ID: 10681352
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility testing of Danish isolates of Capnocytophaga and CDC group DF-2 bacteria.
Bremmelgaard A; Pers C; Kristiansen JE; Korner B; Heltberg O; Frederiksen W
APMIS; 1989 Jan; 97(1):43-8. PubMed ID: 2914105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
